(MENAFN- ProactiveInvestors)
Limited () directors have increased their shareholdings in the company through participation in its $5.55 million share placement priced at $1.50 per share that was announced in July.
The shares were issued to the directors following the receipt of shareholder approval in November.
Shares in are currently trading at $2.55.
Chairman Dr. Peter Neustadt acquired 200000 shares for $300000 bringing his total holding up to 3702023 shares.
Non-executive director Lee Ausburn acquired 50000 shares for $75000 while Robert Scherini bought 20000 shares for $30000.
Ausburn now has 73999 shares while Scherini has 30000 shares.
At the beginning of FY2015 the company announced the share placement and share purchase plan to raise up to $7.05 million.
Proceeds will be used to double its production capacity phase in digital equipment in the production process and fund working capital for growing operations.
Highlighting the interest in the company and growing sales of its sleep apnea products the share purchase plan closed heavily oversubscribed with shareholders applying for $6.1 million worth of shares well above the maximum of $1.5 million available.
In November reached the benchmark of 200000 non-invasive medical devices fitted to patients to treat obstructive sleep apnoea since start of its operations in 2004.
Proactive Investors Australia is the market leader in producing news articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia UK North America and Hong Kong / China.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.